...
首页> 外文期刊>Experimental Lung Research >Aerosolized clindamycin is superior to aerosolized dexamethasone or clindamycin-dexamethasone combination in the treatment of severe Porphyromonas gingivalis aspiration pneumonia in an experimental murine model
【24h】

Aerosolized clindamycin is superior to aerosolized dexamethasone or clindamycin-dexamethasone combination in the treatment of severe Porphyromonas gingivalis aspiration pneumonia in an experimental murine model

机译:在实验鼠模型中,气雾化的克林霉素优于雾化的地塞米松或克林霉素-地塞米松联合治疗严重牙龈卟啉单胞菌吸入性肺炎

获取原文
获取原文并翻译 | 示例
           

摘要

Adjunctive corticosteroid treatment to reduce excessive local inflammatory response in pneumonia is controversial. To study the effects of an early local adjunct dexamethasone treatment on the course of pneumonia and inflammatory/cytokine response, mice were intratracheally inoculated with live Porphyromonas gingivalis and treated with either clindamycin (C), dexamethasone (D), C+D combination, or were not treated (Pg). Six mice from each group were euthanized at 6, 24, 72, and 168 hours after inoculation. Levels of tumor necrosis factor (TNF)-α, soluble TNF-α receptors (sTNFR1 and sTNFR2), interleukin (IL)-1β, and IL-6 in the serum and lung-homogenate supernatant were determined. Lung samples were histopathologically assessed and all findings compared to those found in 24 sham-inoculated mice (phosphate-buffered saline [PBS]). Severe P. gingivalisinduced bronchopneumonia progressed from 24 hours, peaked at 72 hours, and resolved after 168 hours with changes in local and systemic cytokine levels. Clindamycin-treated mice developed only mild bronchopneumonia that resolved fast (72 hours) with an early (624 hours) normalization of local and systemic cytokine levels. Similar course of pneumonia and cytokine level changes were observed in mice treated with C+D, but later. Early (624 hours) local elevation of sTNFRs was observed in C and C+D groups of mice, whereas nontreated (Pg) mice had increased systemic sTNFRs. Severe bronchopneumonia with delayed resolution was observed in D-group mice, with an early local and systemic decrease in sTNFR1 and persistent elevation of local TNF-α. Clindamycin or a clindamycin-dexamethasone combination treatment significantly improves the course of P. gingivalis-aspiration pneumonia, but more so if clindamycin alone is used. A favorable course of pneumonia seems to be associated with an early elevation of sTNFRs and normalization of TNF-α.
机译:减少肺炎中过度局部炎症反应的皮质类固醇辅助治疗存在争议。为了研究早期局部辅助地塞米松治疗对肺炎和炎症/细胞因子反应的影响,对气管内接种活牙龈卟啉单胞菌并用克林霉素(C),地塞米松(D),C + D组合或没有得到治疗(Pg)。接种后第6、24、72和168小时对每组的六只小鼠实施安乐死。测定血清和肺匀浆上清液中的肿瘤坏死因子(TNF)-α,可溶性TNF-α受体(sTNFR1和sTNFR2),白介素(IL)-1β和IL-6的水平。对肺样品进行了组织病理学评估,并将所有发现与24只假接种小鼠(磷酸盐缓冲液[PBS])中发现的结果进行了比较。严重的牙龈卟啉单胞菌诱发的支气管肺炎从24小时开始发展,在72小时达到峰值,并在168小时后随着局部和全身细胞因子水平的改变而消退。克林霉素治疗的小鼠仅发展出轻度的支气管肺炎,可快速(72小时)消退,并早期(624小时)使局部和全身细胞因子水平正常化。在用C + D处理的小鼠中观察到了类似的肺炎病程和细胞因子水平变化,但后来出现了。在C和C + D组小鼠中观察到sTNFRs的早期(624小时)局部升高,而未治疗的(Pg)小鼠的全身sTNFRs升高。在D-组小鼠中观察到严重的支气管肺炎,其延迟的延迟,sTNFR1的早期局部和全身性降低以及局部TNF-α的持续升高。克林霉素或克林霉素-地塞米松联合治疗可显着改善牙龈卟啉单胞菌吸入性肺炎的病程,但如果单独使用克林霉素则更是如此。肺炎的良好病程似乎与sTNFRs的早期升高和TNF-α的正常化有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号